BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18414477)

  • 21. Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis.
    Miller TM; Kim SH; Yamanaka K; Hester M; Umapathi P; Arnson H; Rizo L; Mendell JR; Gage FH; Cleveland DW; Kaspar BK
    Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19546-51. PubMed ID: 17164329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Astrocyte-targeting RNA interference against mutated superoxide dismutase 1 induces motoneuron plasticity and protects fast-fatigable motor units in a mouse model of amyotrophic lateral sclerosis.
    Rochat C; Bernard-Marissal N; Källstig E; Pradervand S; Perrin FE; Aebischer P; Raoul C; Schneider BL
    Glia; 2022 May; 70(5):842-857. PubMed ID: 34978340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell death in amyotrophic lateral sclerosis: interplay between neuronal and glial cells.
    Ferri A; Nencini M; Casciati A; Cozzolino M; Angelini DF; Longone P; Spalloni A; Rotilio G; Carrì MT
    FASEB J; 2004 Aug; 18(11):1261-3. PubMed ID: 15208263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
    Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ
    J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An RNAi strategy for treatment of amyotrophic lateral sclerosis caused by mutant Cu,Zn superoxide dismutase.
    Xia XG; Zhou H; Zhou S; Yu Y; Wu R; Xu Z
    J Neurochem; 2005 Jan; 92(2):362-7. PubMed ID: 15663483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
    Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
    Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS.
    Shan X; Vocadlo D; Krieger C
    Neurosci Lett; 2009 Jul; 458(2):70-4. PubMed ID: 19379791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
    Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
    Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
    Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ
    Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS.
    Kirby J; Halligan E; Baptista MJ; Allen S; Heath PR; Holden H; Barber SC; Loynes CA; Wood-Allum CA; Lunec J; Shaw PJ
    Brain; 2005 Jul; 128(Pt 7):1686-706. PubMed ID: 15872021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cellular mRNA expression of GABA and glutamate receptors in spinal motor neurons of SOD1 mice.
    Petri S; Schmalbach S; Grosskreutz J; Krampfl K; Grothe C; Dengler R; Van Den Bosch L; Robberecht W; Bufler J
    J Neurol Sci; 2005 Nov; 238(1-2):25-30. PubMed ID: 16087196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hsp27 and Hsp70 administered in combination have a potent protective effect against FALS-associated SOD1-mutant-induced cell death in mammalian neuronal cells.
    Patel YJ; Payne Smith MD; de Belleroche J; Latchman DS
    Brain Res Mol Brain Res; 2005 Apr; 134(2):256-74. PubMed ID: 15836922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Familial amyotrophic lateral sclerosis and mutations in the Cu/Zn superoxide dismutase gene].
    Nakano R
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1546-8. PubMed ID: 8752459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
    Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Reinholz MM; Merkle CM; Poduslo JF
    Exp Neurol; 1999 Sep; 159(1):204-16. PubMed ID: 10486188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading.
    Subramaniam JR; Lyons WE; Liu J; Bartnikas TB; Rothstein J; Price DL; Cleveland DW; Gitlin JD; Wong PC
    Nat Neurosci; 2002 Apr; 5(4):301-7. PubMed ID: 11889469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model.
    Stoica L; Todeasa SH; Cabrera GT; Salameh JS; ElMallah MK; Mueller C; Brown RH; Sena-Esteves M
    Ann Neurol; 2016 Apr; 79(4):687-700. PubMed ID: 26891182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HoxB2 binds mutant SOD1 and is altered in transgenic model of ALS.
    Zhai J; Lin H; Canete-Soler R; Schlaepfer WW
    Hum Mol Genet; 2005 Sep; 14(18):2629-40. PubMed ID: 16079151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice.
    Hossaini M; Cardona Cano S; van Dis V; Haasdijk ED; Hoogenraad CC; Holstege JC; Jaarsma D
    J Neuropathol Exp Neurol; 2011 Aug; 70(8):662-77. PubMed ID: 21760539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.